glp 1 and parkinson's disease Are GLP-1 diabetes drugs like Ozempic coming for disease? — Parkinson Secrets Parkinson's Disease Weight Loss: A

Serious Risks While rare, there are potential serious risks associated with GLP-1 medications: Pancreatitis: Inflammation of the pancreas, which requires immediate medical attention

Clinical considerations for use of initial combination therapy in type 2 diabetes

Study participants were assigned to low, middle, or high doses of CT-388 or assigned to receive placebo across five dosing cohorts with different up-titration schemes

Pathare contributed equally

Additional mechanisms such as enhanced lipolysis, increased diuresis, greater energy expenditure may further support preferential FM reduction while preserving lean tissue, a particularly valuable outcome for minimising sarcopenia risk during weight loss

Researchers looked at data from more than 430,000 patients aged 50 and older who took either a GLP-1, sodium-glucose cotransporter 2 inhibitors (SGLT2i), metformin or insulin to manage their diabetes for at least two years